![Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase - ScienceDirect Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523319300166-gr8.jpg)
Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase - ScienceDirect
![Post-translational reduction of Sp1 in MM cells by panobinostat. A. The... | Download Scientific Diagram Post-translational reduction of Sp1 in MM cells by panobinostat. A. The... | Download Scientific Diagram](https://www.researchgate.net/profile/Shingen-Nakamura/publication/309093759/figure/fig2/AS:416757673152518@1476374180675/Post-translational-reduction-of-Sp1-in-MM-cells-by-panobinostat-A-The-indicated-MM-cell.png)
Post-translational reduction of Sp1 in MM cells by panobinostat. A. The... | Download Scientific Diagram
![The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair | Leukemia The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2009.182/MediaObjects/41375_2009_Article_BFleu2009182_Fig1_HTML.jpg)
The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair | Leukemia
![The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators - ScienceDirect The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295219302710-ga1.jpg)
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators - ScienceDirect
![The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma](https://www.spandidos-publications.com/article_images/ijmm/32/4/IJMM-32-04-0860-g02.jpg)
The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma
![Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors | Future Oncology Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.09.36/asset/images/medium/graphic15.gif)
Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors | Future Oncology
![The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma](https://www.spandidos-publications.com/article_images/ijmm/32/4/IJMM-32-04-0860-g00.jpg)
The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma
Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
![Pan-HDAC inhibitor panobinostat, as a single agent or in combination with PI3K inhibitor, induces apoptosis in APL cells: An emerging approach to overcome MSC-induced resistance - ScienceDirect Pan-HDAC inhibitor panobinostat, as a single agent or in combination with PI3K inhibitor, induces apoptosis in APL cells: An emerging approach to overcome MSC-induced resistance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1357272520300510-gr8.jpg)
Pan-HDAC inhibitor panobinostat, as a single agent or in combination with PI3K inhibitor, induces apoptosis in APL cells: An emerging approach to overcome MSC-induced resistance - ScienceDirect
![New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Leukemia New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fleu.2013.350/MediaObjects/41375_2014_Article_BFleu2013350_Fig1_HTML.jpg)
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Leukemia
![Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies - Imai - 2016 - Cancer Science - Wiley Online Library Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies - Imai - 2016 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/32178a40-b66b-4eb5-9766-d713a3eaf957/cas13062-fig-0003-m.jpg)
Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies - Imai - 2016 - Cancer Science - Wiley Online Library
![Depicted mechanisms of action of emerging therapies in the treatment of... | Download Scientific Diagram Depicted mechanisms of action of emerging therapies in the treatment of... | Download Scientific Diagram](https://www.researchgate.net/publication/313777151/figure/fig1/AS:462484147576832@1487276221278/Depicted-mechanisms-of-action-of-emerging-therapies-in-the-treatment-of-multiple-myeloma.png)
Depicted mechanisms of action of emerging therapies in the treatment of... | Download Scientific Diagram
![Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies - Imai - 2016 - Cancer Science - Wiley Online Library Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies - Imai - 2016 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1871d207-7a10-484f-9b1b-490b0dc62fbb/cas13062-toc-0001-m.jpg)
Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies - Imai - 2016 - Cancer Science - Wiley Online Library
![Panobinostat profiling in rat tissue in vivo and ex vivo a, Tissue-TPP... | Download Scientific Diagram Panobinostat profiling in rat tissue in vivo and ex vivo a, Tissue-TPP... | Download Scientific Diagram](https://www.researchgate.net/publication/338705582/figure/fig2/AS:941109928816654@1601389500907/Panobinostat-profiling-in-rat-tissue-in-vivo-and-ex-vivo-a-Tissue-TPP-work-flow-for.png)
Panobinostat profiling in rat tissue in vivo and ex vivo a, Tissue-TPP... | Download Scientific Diagram
![PPP3CA is a client protein of HSP90 and is protected from proteasomal... | Download Scientific Diagram PPP3CA is a client protein of HSP90 and is protected from proteasomal... | Download Scientific Diagram](https://www.researchgate.net/publication/332219285/figure/fig1/AS:744155949068288@1554432012907/PPP3CA-is-a-client-protein-of-HSP90-and-is-protected-from-proteasomal-degradation-by.png)
PPP3CA is a client protein of HSP90 and is protected from proteasomal... | Download Scientific Diagram
![The Design, Synthesis, and Evaluation of Hypoxia-Activated Prodrugs of the KDAC Inhibitor Panobinostat - preLights The Design, Synthesis, and Evaluation of Hypoxia-Activated Prodrugs of the KDAC Inhibitor Panobinostat - preLights](https://prelights.biologists.com/wp-content/uploads/2021/02/20210202-Hypoxia-activated-prodrugs-Fig.-1.jpg)
The Design, Synthesis, and Evaluation of Hypoxia-Activated Prodrugs of the KDAC Inhibitor Panobinostat - preLights
![Cancers | Free Full-Text | HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action | HTML Cancers | Free Full-Text | HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action | HTML](https://www.mdpi.com/cancers/cancers-11-00475/article_deploy/html/images/cancers-11-00475-g001.png)